EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease modifying antirheumatic drugs: 2025 update

Smolen JS., Edwards CJ., Konzett V., Laskou F., Aletaha D., Caporali R., Dörner T., Hyrich KL., Mateus E., Pope J., Primdahl J., de Souza, S., Stamm T., Takeuchi T., van der Heijde D., Verschueren P., Winthrop KL., Alvaro-Gracia JM., Askling J., Bathon J., Buch MH., Burmester GR., Codreanu C., Conaghan PG., Cutolo M., Fautrel B., Fonsec J., Gossec L., Haavardsholm E., Lund Hetland M., Iagnocco A., Juge P-A., Li Z., Moe RH., Nash P., Poór G., Rubbert-Roth A., dos Santos Sobrin R., Schulze-Koops H., Shumnalieva R., Senolt L., Silva-Fernandez L., Strangfeld A., Taylor P., Turesson C., van Duuren E., de Wit, M., Xavier R., Kerschbaumer A., Landewé RBM.

Type

Journal article

Publisher

BMJ Publishing Group

Publication Date

2026-02-02T00:00:00+00:00

Permalink Close